Steward Partners Investment Advisory’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.04M Buy
165,562
+5,925
+4% +$73K 0.02% 714
2025
Q1
$983K Buy
159,637
+9,803
+7% +$60.4K 0.01% 932
2024
Q4
$1.21M Buy
149,834
+3,221
+2% +$26.1K 0.01% 808
2024
Q3
$1.18M Buy
146,613
+3,910
+3% +$31.6K 0.01% 800
2024
Q2
$618K Sell
142,703
-15,210
-10% -$65.9K 0.01% 970
2024
Q1
$670K Buy
157,913
+19,905
+14% +$84.4K 0.01% 940
2023
Q4
$519K Buy
138,008
+4,195
+3% +$15.8K 0.01% 988
2023
Q3
$495K Buy
133,813
+2,100
+2% +$7.77K 0.01% 923
2023
Q2
$522K Buy
131,713
+9,151
+7% +$36.3K 0.01% 921
2023
Q1
$507K Sell
122,562
-15,500
-11% -$64.2K 0.01% 921
2022
Q4
$583K Sell
138,062
-4,000
-3% -$16.9K 0.01% 846
2022
Q3
$402K Sell
142,062
-6,530
-4% -$18.5K 0.01% 927
2022
Q2
$597K Buy
148,592
+2,912
+2% +$11.7K 0.01% 799
2022
Q1
$798K Sell
145,680
-1,200
-0.8% -$6.57K 0.01% 756
2021
Q4
$668K Sell
146,880
-21,185
-13% -$96.3K 0.01% 846
2021
Q3
$782K Buy
168,065
+20,900
+14% +$97.2K 0.01% 743
2021
Q2
$1.01M Buy
147,165
+8,635
+6% +$59.3K 0.02% 663
2021
Q1
$1.38M Buy
138,530
+63,321
+84% +$633K 0.02% 534
2020
Q4
$559K Sell
75,209
-1,001
-1% -$7.44K 0.01% 728
2020
Q3
$460K Sell
76,210
-3,800
-5% -$22.9K 0.01% 697
2020
Q2
$504K Buy
80,010
+5,324
+7% +$33.5K 0.01% 625
2020
Q1
$268K Buy
74,686
+5,926
+9% +$21.3K 0.01% 706
2019
Q4
$500K Buy
68,760
+9,604
+16% +$69.8K 0.01% 626
2019
Q3
$377K Sell
59,156
-5,622
-9% -$35.8K 0.01% 664
2019
Q2
$581K Buy
64,778
+26,500
+69% +$238K 0.02% 517
2019
Q1
$361K Buy
38,278
+22,500
+143% +$212K 0.02% 592
2018
Q4
$101K Buy
15,778
+1,600
+11% +$10.2K ﹤0.01% 747
2018
Q3
$69K Buy
14,178
+3,960
+39% +$19.3K ﹤0.01% 1066
2018
Q2
$12K Buy
10,218
+500
+5% +$587 ﹤0.01% 1664
2018
Q1
$8K Hold
9,718
﹤0.01% 1638
2017
Q4
$24K Hold
9,718
﹤0.01% 1053
2017
Q3
$25K Buy
9,718
+1,600
+20% +$4.12K ﹤0.01% 877
2017
Q2
$17K Buy
8,118
+1,800
+28% +$3.77K ﹤0.01% 907
2017
Q1
$51K Buy
+6,318
New +$51K 0.01% 544